cannabis indica

HIV/AIDS

O acervo do Cannabis Indica reúne 131 estudos científicos que tocam a condição HIV/AIDS, publicados entre 1989 e 2024. Pela leitura automatizada, 83 (63%) foram classificados como favoráveis, 30 (23%) como inconclusivos e 18 (14%) como desfavoráveis — uma leitura de máquina, feita para navegar, não para concluir. O desenho mais frequente é metanálise (68 estudos), seguido de ensaio clínico (18). Os compostos mais presentes são THC Farmacêutico, Tetraidrocanabinol (THC) e Anandamida (AEA). Aparece com frequência ao lado de Dor, Inflamação e Náusea e Vômito.

Estudos indexados
131
Período coberto
1989–2024
Favoráveis
83 · 63%
Inconclusivos
30 · 23%
Desfavoráveis
18 · 14%
Termo original
HIV/AIDS

O acervo em números

Tipo de estudo

Metanálise68
Ensaio Clínico18
Ensaio Clínico Duplo-Cego14
Estudo Laboratorial13
Estudo em Animais9
Metanálise Clínica9

Direção do resultado

Favorável83
Inconclusivo30
Desfavorável18

Por década

1980s1
1990s4
2000s11
2010s48
2020s67

131 estudos

Filtrar e buscar no acervo →
  1. 2024

    Antiviral Potential of Spirulina in Individuals with Human Immunodeficiency Virus or Hepatis C Virus Infections: A Systematic Review and Meta-Analysis

    FavorávelMetanálise ClínicaHepatite
  2. 2024

    Patterns of Polysubstance Use in Young Black and Latinx Sexual Minority Men and Transgender Women and Its Association with Sexual Partnership Factors: The PUSH Study

  3. 2024

    The Impact of Cannabis Use on Cognition in People with HIV: Evidence of Function-Dependent Effects and Mechanisms from Clinical and Preclinical Studies

    InconclusivoMetanáliseInflamaçãoDisfunção CognitivaDoenças Neurodegenerativas
  4. 2023

    A Case of Panic Attacks Developing After 10 Years of Chronic Cannabis Use in a Patient With No Prior Psychiatric History

    DesfavorávelMetanáliseDorCâncerInflamaçãoTetraidrocanabinol (THC)Canabigerol (CBG)+13
  5. 2023

    A Systematic Review of Risk Factors and Consequences of Nyaope Usage: The Illicit Street Drug Containing HIV Antiretrovirals

  6. 2023

    Amphetamine use and its associations with antiretroviral adherence and viral load among sexual minority men and transgender women living with HIV

    DesfavorávelEnsaio ClínicoDependência QuímicaDependência — CannabisDependência — Álcool+2
  7. 2023

    Biotechnological Fungal Platforms for the Production of Biosynthetic Cannabinoids

    FavorávelEstudo LaboratorialDorCâncerInflamaçãoTetraidrocanabinol (THC)THC Farmacêutico+25
  8. 2023

    Cannabis-Induced Acute Encephalopathy in a 94-Year-Old Woman Due to Family Administration of Cannabidiol (CBD) Products: A Case Report

  9. 2023

    Co-use of cigarettes and cannabis among people with HIV: Results from a randomized controlled smoking cessation trial

  10. 2023

    Effects of Oral Cannabinoids on Systemic Inflammation and Viral Reservoir Markers in People with HIV on Antiretroviral Therapy: Results of the CTN PT028 Pilot Clinical Trial

    FavorávelEnsaio ClínicoInflamação
  11. 2023

    Endocannabinoid System and Exogenous Cannabinoids in Depression and Anxiety: A Review

  12. 2023

    Medical Cannabis Received by Patients According to Qualifying Condition in a US State Cannabis Program: Product Choice, Dosing, and Age-Related Trends

    FavorávelMetanáliseDorCâncerDor — CrônicaTHC FarmacêuticoCBD Farmacêutico+16
  13. 2023

    Mental health and substance use screening in HIV primary care before and during the early COVID-19 pandemic

    InconclusivoMetanáliseDependência QuímicaDependência — CannabisAnsiedade+6
  14. 2023

    Phytocannabinoids: Pharmacological effects, biomedical applications, and worldwide prospection

    InconclusivoMetanálise ClínicaDorCâncerAnsiedadeTHC FarmacêuticoTHC:CBD Farmacêutico+9
  15. 2023

    Preventing Neurocognitive Decline in Adults Aging with HIV: Implications for Practice and Research

    FavorávelMetanáliseInflamaçãoDisfunção CognitivaDoenças Neurodegenerativas+3
  16. 2023

    Ulceration and a White Lesion of the Tongue in a Male HIV Positive Patient: A Journey on the Avenue of Differential Diagnoses in Search of a Solution

    DesfavorávelMetanáliseDorInflamaçãoEfeitos Adversos da CannabisMicrobioma+6
  17. 2023

    Weeding Out the Culprit: Cannabinoid-Associated Stevens-Johnson Syndrome

    DesfavorávelMetanáliseDorEfeitos Adversos da CannabisAnsiedade+4
  18. 2022

    Acute pancreatitis as a rare adverse event among cannabis users: A systematic review

    DesfavorávelMetanáliseDorInflamaçãoEfeitos Adversos da CannabisAnandamida (AEA)+16
  19. 2022

    Anti-inflammatory effects of recreational marijuana in virally suppressed youth with HIV-1 are reversed by use of tobacco products in combination with marijuana

    InconclusivoEnsaio ClínicoInflamaçãoEfeitos Adversos da Cannabis
  20. 2022

    Cannabinoids Reduce Extracellular Vesicle Release from HIV-1 Infected Myeloid Cells and Inhibit Viral Transcription

    FavorávelEstudo LaboratorialInflamaçãoDoenças NeurodegenerativasDoenças Priônicas
  21. 2022

    Cannabinoids: Therapeutic Use in Clinical Practice

  22. 2022

    Cannabis in Palliative Care: A Systematic Review of Current Evidence

    InconclusivoMetanáliseCâncerEpilepsiaInsônia e Distúrbios do Sono+6
  23. 2022

    Cannabis Use as a Protective Factor Against Overweight in HIV-Hepatitis C Virus Co-Infected People (ANRS CO13 HEPAVIH Cohort)

    FavorávelMetanáliseObesidadeSíndrome MetabólicaHepatite
  24. 2022

    Does Cannabidiol Have a Benefit as a Supportive Care Drug in Cancer?

  25. 2022

    Gut microbiota alterations after switching from a protease inhibitor or efavirenz to raltegravir in a randomized, controlled study

    InconclusivoEstudo LaboratorialProteína Ligadora de Ácidos Graxos (FABP)Microbioma
  26. 2022

    HCV cure: an appropriate moment to reduce cannabis use in people living with HIV? (ANRS CO13 HEPAVIH data)

    FavorávelMetanáliseDependência — CannabisHepatite
  27. 2022

    Herbal Approaches to Pediatric Functional Abdominal Pain

    InconclusivoMetanáliseDorInflamaçãoDor — CrônicaTHC Farmacêutico+10
  28. 2022

    Malignant Syphilis in a Female Patient: A Case Report and Mini-Review

    DesfavorávelMetanáliseCâncerInflamaçãoEfeitos Adversos da Cannabis+11
  29. 2022

    Pilot clinical and pharmacokinetic study of Δ9-Tetrahydrocannabinol (THC)/Cannabidiol (CBD) nanoparticle oro-buccal spray in patients with advanced cancer experiencing uncontrolled pain

  30. 2022

    Practical Considerations for the Use of Cannabis in Cancer Pain Management—What a Medical Oncologist Should Know

  31. 2022

    Safety and Tolerability of Oral Cannabinoids in People Living with HIV on Long-Term ART: A Randomized, Open-Label, Interventional Pilot Clinical Trial (CTNPT 028)

    FavorávelEnsaio ClínicoInflamaçãoHepatiteTetraidrocanabinol (THC)THC:CBD Farmacêutico+1
  32. 2022

    Tina's ParTy line: Polysubstance use patterns in sexual minority men living with HIV who use methamphetamine

    DesfavorávelEnsaio ClínicoDependência QuímicaDependência — CannabisDependência — Álcool+3
  33. 2022

    TRPV1: A Common Denominator Mediating Antinociceptive and Antiemetic Effects of Cannabinoids

  34. 2021

    A Cannabinoid 2-Selective Agonist Inhibits Allogeneic Skin Graft Rejection In Vivo

  35. 2021

    A Mapping Literature Review of Medical Cannabis Clinical Outcomes and Quality of Evidence in Approved Conditions in the USA from 2016 to 2019

    InconclusivoMetanáliseDorCâncerDor — CrônicaTHC FarmacêuticoCBD Farmacêutico+9
  36. 2021

    Beneficial Effects of Cannabis on Blood-Brain Barrier Function in Human Immunodeficiency Virus

    FavorávelEnsaio ClínicoInflamaçãoTraumatismo Cranioencefálico
  37. 2021

    Benign ethnic neutropenia in a South African population, and its association with HIV acquisition and adverse event reporting in an HIV vaccine clinical trial

    DesfavorávelMetanálise ClínicaEfeitos Adversos da Cannabis
  38. 2021

    Cannabinoid control of gingival immune activation in chronically SIV-infected rhesus macaques involves modulation of the indoleamine-2,3-dioxygenase-1 pathway and salivary microbiome

    FavorávelEstudo em AnimaisInflamaçãoInfecções BacterianasDoença PeriodontalMicrobioma
  39. 2021

    Cannabis and Inflammation in HIV: A Review of Human and Animal Studies

  40. 2021

    Cannabis and the Gut-Brain Axis Communication in HIV Infection

  41. 2021

    Cannabis use and reduced risk of elevated fatty liver index in HIV-HCV co-infected patients: a longitudinal analysis (ANRS CO13 HEPAVIH)

    FavorávelMetanáliseHepatite
  42. 2021

    Cannabis use, pain interference, and prescription opioid receipt among persons with HIV: a target trial emulation study

    InconclusivoMetanáliseDorDor — CrônicaDependência — Opioides
  43. 2021

    Correlates of High HIV Viral Load and Antiretroviral Therapy Adherence Among Viremic Youth in the United States Enrolled in an Adherence Improvement Intervention

    DesfavorávelEnsaio ClínicoDependência QuímicaDependência — CannabisDepressão
  44. 2021

    Daily Cannabis Use is Associated With Lower CNS Inflammation in People With HIV

    FavorávelMetanáliseInflamação
  45. 2021

    Human Laboratory Models of Cannabis Use: Applications for Clinical and Translational Psychiatry Research

    FavorávelMetanáliseDorDependência QuímicaCâncer+16
  46. 2021

    Lack of Association Between Recent Cannabis Use and Advanced Liver Fibrosis Among HIV-positive Heavy Drinkers

    InconclusivoMetanáliseDependência QuímicaInflamaçãoDependência — Álcool+2
  47. 2021

    Medical Cannabis for Chronic Noncancer Pain: A Systematic Review of Health Care Recommendations

    FavorávelMetanáliseDorDor — Crônica
  48. 2021

    Moderator effects in a randomized controlled trial of the Common Elements Treatment Approach (CETA) for intimate partner violence and hazardous alcohol use in Zambia

    FavorávelMetanáliseDependência QuímicaDependência — CannabisDepressão+3
  49. 2021

    Natural and Synthetic Cannabinoids: Pharmacology, Uses, Adverse Drug Events, and Drug Interactions

  50. 2021

    Prevalence and impact of comorbid chronic pain and cigarette smoking among people living with HIV

    DesfavorávelMetanáliseDorDependência — CannabisDor — Crônica
  51. 2021

    Self-Reported Cannabis Use and Markers of Inflammation in Men Who Have Sex With Men With and Without HIV

    InconclusivoMetanáliseInflamação
  52. 2021

    Targeting the endocannabinoid system for management of HIV-associated neuropathic pain: A systematic review

  53. 2021

    The Current and Potential Application of Medicinal Cannabis Products in Dentistry

  54. 2021

    The Link between Cannabis Use, Immune System, and Viral Infections

    DesfavorávelMetanáliseInflamaçãoCOVID-19Hepatite
  55. 2021

    The role of cannabis in pain management among people living with HIV who use drugs: A qualitative study

    FavorávelMetanálise
  56. 2021

    VOICES: An efficacious trauma-informed, gender-responsive cannabis use intervention for justice and school-referred girls with lifetime substance use history

  57. 2020

    Attenuation of Oxidative Stress by Cannabinoids and Cannabis Extracts in Differentiated Neuronal Cells

  58. 2020

    Cannabidiol for Viral Diseases: Hype or Hope?

    InconclusivoMetanáliseHepatiteEncefalite e MieliteDoenças Priônicas+4
  59. 2020

    Cannabis Exposure Is Associated With a Lower Likelihood of Neurocognitive Impairment in People Living With HIV

    FavorávelMetanáliseDisfunção Cognitiva
  60. 2020

    Cannabis use is associated with greater total sleep time in middle-aged and older adults with and without HIV: A preliminary report utilizing digital health technologies

    FavorávelMetanáliseInsônia e Distúrbios do Sono
  61. 2020

    Daily and near-daily cannabis use is associated with HIV viral load suppression in people living with HIV who use cocaine

    FavorávelMetanálise
  62. 2020

    HCV-Related Mortality Among HIV/HCV Co-infected Patients: The Importance of Behaviors in the HCV Cure Era (ANRS CO13 HEPAVIH Cohort)

    FavorávelMetanáliseHepatite
  63. 2020

    Impact of Cannabis Use on Brain Structure and Function in Suppressed HIV Infection

    InconclusivoMetanálise
  64. 2020

    Self-reported Cannabis Use and Changes in Body Mass Index, CD4 T-cell Counts, and HIV-1 RNA Suppression in Treated Persons with HIV

    InconclusivoMetanálise
  65. 2020

    Targeting Cannabinoid Receptor 2 on Peripheral Leukocytes to Attenuate Inflammatory Mechanisms Implicated in HIV-Associated Neurocognitive Disorder

    FavorávelMetanálise
  66. 2020

    The Effect of Orally Administered Dronabinol on Optic Nerve Head Blood Flow in Healthy Subjects—A Randomized Clinical Trial

  67. 2020

    The neurocognitive effects of a past cannabis use disorder in a diverse sample of people living with HIV

    FavorávelMetanálise
  68. 2019

    Cannabinoid Attenuation of Intestinal Inflammation in Chronic SIV-Infected Rhesus Macaques Involves T Cell Modulation and Differential Expression of Micro-RNAs and Pro-inflammatory Genes

  69. 2019

    Cannabinoids and inflammation: Implications for People Living with HIV

    InconclusivoMetanáliseInflamação
  70. 2019

    Cannabis Consumption in People Living with HIV: Reasons for Use, Secondary Effects, and Opportunities for Health Education

    InconclusivoMetanáliseDorEfeitos Adversos da CannabisAnsiedade+1
  71. 2019

    Medical Cannabinoids for Cancer Cachexia: A Systematic Review and Meta-Analysis

    FavorávelMetanáliseDorCâncerEsclerose Múltipla+7
  72. 2019

    Priority Considerations for Medicinal Cannabis-Related Research

    FavorávelMetanáliseDorCâncerAnsiedade+16
  73. 2019

    Synergistic effects of marijuana abuse and HIV infection on neural activation during a cognitive interference task

    DesfavorávelMetanáliseEfeitos Adversos da CannabisDisfunção Cognitiva
  74. 2018

    Association of Cannabis, Stimulant, and Alcohol use with Mortality Prognosis Among HIV-Infected Men

    InconclusivoMetanáliseEfeitos Adversos da Cannabis
  75. 2018

    Cannabis Use is Associated with Lower Odds of Prescription Opioid Analgesic Use Among HIV-Infected Individuals with Chronic Pain

    FavorávelMetanáliseDorDependência QuímicaDependência — Cannabis+5
  76. 2018

    Dronabinol oral solution in the management of anorexia and weight loss in AIDS and cancer

  77. 2018

    Lifetime Marijuana and Alcohol Use, and Cognitive Dysfunction in People with Human Immunodeficiency Virus Infection

  78. 2018

    Medical use of cannabis: Italian and European legislation.

  79. 2018

    Memory impairment in HIV-infected individuals with early and late initiation of regular marijuana use

    DesfavorávelMetanáliseEfeitos Adversos da CannabisDisfunção Cognitiva
  80. 2018

    Posttraumatic Stress Symptoms and Emerging Adult Sexual Minority Men: Implications for Assessment and Treatment of Childhood Sexual Abuse

    FavorávelMetanáliseDependência QuímicaDependência — CannabisAnsiedade+6
  81. 2018

    Therapeutic Benefit of Smoked Cannabis in Randomized Placebo-Controlled Studies

  82. 2018

    Δ9-Tetrahydrocannabinold (THC) suppresses secretion of IFNα by plasmacytoid dendritic cells (pDC) from healthy and HIV-infected individuals.

    FavorávelEstudo Laboratorial
  83. 2017

    No significant effect of cannabis use on the count and percentage of circulating CD4 T-cells in HIV-HCV co-infected patients (ANRS CO13-HEPAVIH French cohort).

    InconclusivoMetanálise
  84. 2017

    Targeting Cannabinoid Signaling in the Immune System: “High”-ly Exciting Questions, Possibilities, and Challenges.

  85. 2016

    Cannabidivarin for HIV-Associated Neuropathic Pain: A Randomized, Blinded, Controlled Clinical Trial

    InconclusivoEnsaio Clínico Duplo-CegoDorDor — Neuropatia PeriféricaCanabidivarina (CBDV)
  86. 2016

    Cannabinoids in Palliative Care: Systematic Review and Meta-Analysis of Efficacy, Tolerability and Safety

    InconclusivoMetanálise ClínicaDorCâncerInsônia e Distúrbios do Sono+4
  87. 2016

    Reduced Plasma Levels of sCD14 and I-FABP in HIV-infected Patients with Mesalazine-treated Ulcerative Colitis

  88. 2016

    Simultaneous Activation Of Induced Heterodimerization Between CXCR4 Chemokine Receptor And Cannabinoid Receptor 2 (CB2) Reveal A Mechanism For Regulation Of Tumor Progression

  89. 2015

    A 4-week pilot study with the cannabinoid receptor agonist dronabinol and its effect on metabolic parameters in a randomized trial

    FavorávelEnsaio Clínico Duplo-CegoDorDoenças Cardiovasculares (DCV)Dor — AgudaTHC Farmacêutico+3
  90. 2015

    Cannabinoid inhibits HIV-1 Tat-stimulated adhesion of human monocyte-like cells to extracellular matrix proteins.

    FavorávelEstudo Laboratorial2-Araquidonoilglicerol (2-AG)Canabinoide Sintético (não especificado)+5
  91. 2015

    Cannabis Use and Reduced Risk of Insulin Resistance in HIV-HCV Infected Patients: A Longitudinal Analysis (ANRS CO13 HEPAVIH)

    FavorávelMetanáliseDiabetesSíndrome MetabólicaHepatite
  92. 2015

    Chronic Administration of Δ9-Tetrahydrocannabinol Induces Intestinal Anti-Inflammatory MicroRNA Expression during Acute Simian Immunodeficiency Virus Infection of Rhesus Macaques.

    FavorávelEstudo em AnimaisImunodeficiência por TraumaTetraidrocanabinol (THC)
  93. 2015

    Efficacy and adverse effects of medical marijuana for chronic noncancer pain: Systematic review of randomized controlled trials

    FavorávelMetanálise ClínicaDorDor — CrônicaEsclerose MúltiplaTetraidrocanabinol (THC)+5
  94. 2015

    High-intensity Cannabis Use Associated With Lower Plasma Human Immunodeficiency virus-1 RNA Viral Load Among Recently Infected People Who Use Injection Drugs

    FavorávelMetanálise
  95. 2015

    Modulation of HIVGP120 Antigen-Specific Immune Responses In Vivo by Δ9-Tetrahydrocannabinol.

    FavorávelEstudo em Animais
  96. 2015

    Safety of oral dronabinol during opioid withdrawal in humans

  97. 2015

    Δ9-tetrahydrocannabinol treatment during human monocyte differentiation reduces macrophage susceptibility to HIV-1 infection.

    FavorávelEstudo LaboratorialTetraidrocanabinol (THC)Canabinoides Sintéticos JWH-x+1
  98. 2014

    Modulation of Gut-Specific Mechanisms by Chronic Δ9-Tetrahydrocannabinol Administration in Male Rhesus Macaques Infected with Simian Immunodeficiency Virus: A Systems Biology Analysis.

    FavorávelEstudo em AnimaisTetraidrocanabinol (THC)
  99. 2013

    Attenuation of HIV-1 replication in macrophages by cannabinoid receptor 2 agonists.

    FavorávelEstudo LaboratorialCanabinoides Sintéticos WIN-xCanabinoides Sintéticos SR-x+2
  100. 2013

    Effects of a topically applied 2% delta-9-tetrahydrocannabinol ophthalmic solution on intraocular pressure and aqueous humor flow rate in clinically normal dogs

    FavorávelEstudo em AnimaisDorCâncerPsicoseTHC Farmacêutico+10
  101. 2013

    Marijuana Smoking Does Not Accelerate Progression of Liver Disease in HIV–Hepatitis C Coinfection: A Longitudinal Cohort Analysis.

    InconclusivoMetanáliseFibroseHepatiteFibrose — Hepática (Cirrose)
  102. 2013

    Oral serum-derived bovine immunoglobulin improves duodenal immune reconstitution and absorption function in patients with HIV enteropathy

    FavorávelEnsaio ClínicoInflamaçãoDiarreiaProteína Ligadora de Ácidos Graxos (FABP)
  103. 2013

    The medical use of cannabis for reducing morbidity and mortality in patients with HIV/AIDS.

    InconclusivoMetanálise ClínicaEndocanabinoide (não especificado)Canabinoide Sintético (não especificado)+1
  104. 2012

    A pilot study of the effects of cannabis on appetite hormones in HIV-infected adult men

    FavorávelEnsaio Clínico Duplo-CegoDiabetesSíndrome MetabólicaAnorexia (perda de apetite)Tetraidrocanabinol (THC)
  105. 2012

    Can oral fluid cannabinoid testing monitor medication compliance and/or cannabis smoking during oral THC and oromucosal Sativex administration?

  106. 2012

    Cannabis—A Valuable Drug That Deserves Better Treatment

  107. 2012

    Novel Δ(9) -tetrahydrocannabinol formulation Namisol® has beneficial pharmacokinetics and promising pharmacodynamic effects

    FavorávelEnsaio Clínico Duplo-CegoDorCâncerEsclerose MúltiplaTHC Farmacêutico+3
  108. 2011

    Cannabinoid Administration Attenuates the Progression of Simian Immunodeficiency Virus

    FavorávelEstudo em AnimaisInflamaçãoImunodeficiência por Trauma
  109. 2011

    Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial

    FavorávelEnsaio Clínico Duplo-CegoDorCâncerInflamaçãoTHC Farmacêutico+9
  110. 2011

    Targets of curcumin

    FavorávelMetanáliseCâncerInflamaçãoDoenças Cardiovasculares (DCV)Cúrcuma+16
  111. 2010

    Cannabinoid Inhibition of Macrophage Migration to the Trans-Activating (Tat) Protein of HIV-1 Is Linked to the CB2 Cannabinoid Receptor

  112. 2010

    Cannabinoids and Viral Infections.

    InconclusivoEstudo LaboratorialHepatiteHerpesHerpes-ZósterAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+7
  113. 2010

    Efficacy and Tolerability of High-Dose Dronabinol Maintenance in HIV-Positive Marijuana Smokers: A Controlled Laboratory Study.

    FavorávelEnsaio Clínico Duplo-CegoTetraidrocanabinol (THC)THC Farmacêutico
  114. 2010

    Immunoregulation of a CB2 Receptor Agonist in a Murine Model of NeuroAIDS

    FavorávelEstudo em Animais
  115. 2010

    Pharmacological treatment of painful HIV-associated sensory neuropathy: a systematic review and meta-analysis of randomised controlled trials

    FavorávelMetanálise ClínicaDorDor — Neuropatia PeriféricaDor — Polineuropatia Inflamatória
  116. 2009

    Marijuana Effectiveness As An HIV Self-care Strategy

    FavorávelMetanáliseAnsiedadeDepressãoNáusea e Vômito
  117. 2009

    Smoked Medicinal Cannabis for Neuropathic Pain in HIV: A Randomized, Crossover Clinical Trial

    FavorávelEnsaio Clínico Duplo-CegoDorDor — Neuropatia PeriféricaTetraidrocanabinol (THC)
  118. 2008

    Cannabinoids Inhibit HIV-1 Gp120-Mediated Insults in Brain Microvascular Endothelial Cells

    FavorávelEstudo Laboratorial2-Araquidonoilglicerol (2-AG)Canabinoides Sintéticos AM-x+2
  119. 2007

    Cannabis In Painful HIV-associated Sensory Neuropathy: A Randomized Placebo-controlled Trial

    FavorávelEnsaio Clínico Duplo-CegoDorDor — Neuropatia PeriféricaTetraidrocanabinol (THC)
  120. 2007

    Use of Dronabinol Improves Appetite and Reverses Weight Loss in HIV/AIDS-Infected Patients.

  121. 2005

    Cannabis use in HIV for pain and other medical symptoms

    FavorávelMetanáliseDorDor — Neuropatia Periférica
  122. 2005

    Dronabinol and marijuana in HIV(+) marijuana smokers: acute effects on caloric intake and mood

    FavorávelEnsaio ClínicoTHC Farmacêutico
  123. 2005

    Mechanisms of HIV-1 inhibition by the lipid mediator N-arachidonoyldopamine.

    FavorávelEstudo LaboratorialAnandamida (AEA)Outros Compostos Relacionados
  124. 2003

    Short-term effects of cannabinoids in patients with HIV-1 infection: a randomized, placebo-controlled clinical trial

    FavorávelEnsaio Clínico Duplo-CegoTHC Farmacêutico
  125. 2002

    Short-term effects of cannabinoids on immune phenotype and function in HIV-1-infected patients

    InconclusivoEnsaio Clínico Duplo-CegoTHC Farmacêutico
  126. 2002

    The effects of cannabinoids on the pharmacokinetics of indinavir and nelfinavir

    InconclusivoEnsaio Clínico Duplo-CegoTHC Farmacêutico
  127. 1998

    Marijuana for intractable hiccups.

    FavorávelMetanáliseSoluços
  128. 1997

    Long-term efficacy and safety of dronabinol for acquired immunodeficiency syndrome-associated anorexia

  129. 1995

    Dronabinol As A Treatment For Anorexia Associated With Weight Loss In Patients With AIDS

    FavorávelEnsaio Clínico Duplo-CegoAnorexia (perda de apetite)CaquexiaTetraidrocanabinol (THC)THC Farmacêutico
  130. 1993

    Effect of dronabinol on nutritional status in HIV infection

  131. 1989

    Nabilone as effective therapy for intractable nausea and vomiting in AIDS

    FavorávelMetanáliseNáusea e VômitoTHC Farmacêutico

Continue por aqui

Perguntas frequentes

Quantos estudos sobre hiv/aids estão indexados no acervo?
São 131 estudos, publicados entre 1989 e 2024. O acervo inteiro tem 7.640 registros.
Que tipos de estudo predominam?
Metanálise: 68 · Ensaio Clínico: 18 · Ensaio Clínico Duplo-Cego: 14 · Estudo Laboratorial: 13 · Estudo em Animais: 9 · Metanálise Clínica: 9. A classificação segue o desenho declarado na fonte.
O que significa a classificação de resultado?
É uma leitura automatizada da conclusão de cada estudo, em três direções — favorável, inconclusivo e desfavorável. Aqui são 83 favoráveis, 30 inconclusivos e 18 desfavoráveis. Serve para navegar o acervo, não para concluir nada clinicamente: a conclusão válida é a do artigo original.

Como citar esta página

ABNT

CANNABIS INDICA. HIV/AIDS — estudos científicos sobre cannabis. 2026. Disponível em: https://cannabisindica.com.br/condicao/hiv-aids/. Acesso em: 13 set. 2026.

APA

Cannabis Indica. (2026). HIV/AIDS — estudos científicos sobre cannabis. https://cannabisindica.com.br/condicao/hiv-aids/

Esta página é um índice de acesso. Ao usar um estudo como evidência, cite o artigo original — o link de cada registro leva à fonte.